Latest news
CAPR Stock Drop: Capricor Therapeutics Clinical Data Leads to 64% Stock Drop and Securities Fraud Class Action for Investors - MorningstarMorningstar · Tue, 04 Aug 2026 15:36:00 GMTCAPR Investigation Notice: Capricor Therapeutics Hit with - GlobeNewswireGlobeNewswire · Mon, 03 Aug 2026 10:36:00 GMTCapricor Therapeutics faces suit over FDA data analysis flaws - scanx.tradescanx.trade · Thu, 30 Jul 2026 07:00:00 GMTThe Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy - GlobeNewswireGlobeNewswire · Wed, 29 Jul 2026 14:05:00 GMTFDA Advisory Committee Votes Against Deramiocel for DMD Cardiomyopathy - NeurologyLiveNeurologyLive · Wed, 29 Jul 2026 07:00:00 GMT